BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24085760)

  • 1. Sarcoidosis induced by tocilizumab: a paradoxical event?
    Nutz A; Pernet C; Combe B; Cohen JD
    J Rheumatol; 2013 Oct; 40(10):1773-4. PubMed ID: 24085760
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab.
    Shono Y; Kamata M; Takeoka S; Ikawa T; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Asako K; Kono H; Tada Y
    J Dermatol; 2018 Aug; 45(8):e217-e218. PubMed ID: 29500868
    [No Abstract]   [Full Text] [Related]  

  • 3. Sarcoidosis and tocilizumab: is there a link?
    Bustamente L; Buscot M; Marquette CH; Roux C
    Clin Exp Rheumatol; 2017; 35(4):716. PubMed ID: 28516883
    [No Abstract]   [Full Text] [Related]  

  • 4. Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?
    Wendling D; Dernis E; Prati C; Frisch E; Delbosc B
    J Rheumatol; 2011 Oct; 38(10):2284. PubMed ID: 21965707
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
    Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
    Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review].
    Scailteux LM; Guedes C; Polard E; Perdriger A
    Presse Med; 2015 Jan; 44(1):4-10. PubMed ID: 25534463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis.
    Rocchi V; Puxeddu I; Cataldo G; Del Corso I; Tavoni A; Bazzichi L; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2014 Aug; 53(8):1527-9. PubMed ID: 24899663
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
    Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
    Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
    [No Abstract]   [Full Text] [Related]  

  • 9. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
    J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract]   [Full Text] [Related]  

  • 10. Sarcoid-related uveitis occurring during adalimumab therapy.
    Seve P; Varron L; Broussolle C; Denis P; Kodjikian L
    Ocul Immunol Inflamm; 2012 Feb; 20(1):59-60. PubMed ID: 22017197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction].
    Ljung L; Smeds J; Persson G; Jirlén L; Toolanen G
    Lakartidningen; 2012 Sep 19-26; 109(38):1678-9. PubMed ID: 23094399
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
    Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
    Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarilumab (Kevzara) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):134-136. PubMed ID: 28787744
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adalimumab induced-inflammatory myopathy in rheumatoid arthritis].
    de Souza FH; Barros TB; Levy-Neto M; Shinjo SK
    Acta Reumatol Port; 2012; 37(2):180-3. PubMed ID: 23149641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sarcoïdosis and anti-TNF: a paradoxical class effect? Analysis of the French Pharmacovigilance system database and literature review].
    Javot L; Tala S; Scala-Bertola J; Massy N; Trenque T; Baldin B; Andréjak M; Gillet P; Petitpain N;
    Therapie; 2011; 66(2):149-54. PubMed ID: 21635863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease diagnosis during adalimumab treatment.
    Fernández Salazar L; Barrio Andrés J; González Hernández JM
    Scand J Gastroenterol; 2013 Feb; 48(2):254-5. PubMed ID: 23061423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis.
    Nishimura K; Saegusa J; Kawano S; Morinobu A
    J Rheumatol; 2012 Sep; 39(9):1904-5. PubMed ID: 22942311
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.
    Honda H; Kida H; Yoshida M; Tomita T; Fujii M; Ihara S; Goya S; Tachibana I; Kawase I
    Mod Rheumatol; 2011 Dec; 21(6):660-4. PubMed ID: 21472474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramsay Hunt syndrome associated with tocilizumab therapy in rheumatoid arthritis: a case report.
    Mimata Y; Akasaka T; Nakano R; Murata T; Kawashima M; Shimamura T
    Int J Rheum Dis; 2013 Jun; 16(3):367-8. PubMed ID: 23981764
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab: a report of two cases.
    Hirao M; Nampei A; Shi K; Yoshikawa H; Nishimoto N; Hashimoto J
    Mod Rheumatol; 2011 Dec; 21(6):673-7. PubMed ID: 21533856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.